Pengyu Yang1, Peng Feng1, Guopeng Tian1

  • 1The Second Medical College of Lanzhou University, Lanzhou, Gansu 730030, PR China; Department of Neurosurgery, Second Hospital of Lanzhou University, Lanzhou, Gansu 730030, PR China; Key Laboratory of Neurology of Gansu Province, Lanzhou University, Lanzhou, Gansu 730030, PR China.

概括

这项研究开发了一种新的恶性瘤预后基因评分 (MGP_Score) 来预测质瘤预后,识别了B2M,SRPX2和SERPINH1等关键生物标志物,以改善诊断和个性化治疗.